Launch of EliA SymphonyS screening assay

We are happy to announce the CE-mark release of the new EliA SymphonyS screening assay that detects relevant antibodies associated with connective tissue diseases (CTDs). A perfect alignment of all single CTD differentiation tests and a further improved combination of sensitivity and specificity ensure high clinical accuracy. It can be easily integrated into laboratory routine as it is performed on the fully automated Phadia Laboratory Systems.  

For further information, please click here .

 

11/3/2017

 

As in all diagnostic testing, the diagnosis is made by the physican based on both test results and the patient history.